SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001745856-22-000001
Filing Date
2022-06-27
Accepted
2022-06-27 16:40:47
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1420
  Complete submission text file 0001745856-22-000001.txt   3141
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address C/O THE COOPER COMPANIES, INC. SUITE 590 PLEASANTON CA 94588
Business Address
Auerbach Robert D (Reporting) CIK: 0001745856 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34810 | Film No.: 221045140